Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In its first registrational Phase 3 obesity trial (TRIUMPH-1), average weight loss reached 28.3% at 80 weeks and up to 30.3% at 104 weeks in a select extension cohort
When stimulants are ineffective, poorly tolerated, or refused by the patient (or the patients parents), validated EEG biofeedback protocols-including SMR training for primarily hyperactive-type ADHD and theta suppression for primarily inattentive-type ADHD-are reasonable alternatives
Stay in touch with your healthcare provider for continuous support and monitoring while you are on semaglutide treatment
Benefits: Glycemic Control: Helps regulate blood sugar levels
US$ 22.95
US$ 19.99
US$ 21.87
US$ 27.77
US$ 24.77
US$ 23.63
US$ 28.93
